First-void urine as an alternative to clinician-collected cervical samples for HPV detection

You are here

Current cervical cancer screening methods, such as Pap smears have limitations, resulting in poor attendance in screening programs. Women would prefer easy, and non-invasive techniques that are not clinician dependent.

Urine as a sample type is well-accepted. Additionally, as Human Papillomavirus (HPV), the most common cause of cervical cancer can be detected in urine, this sample has the potential to reach a wider population, especially women who do not participate in screening.

Novosanis’ Colli-Pee® device allows for standardized, volumetric collection of first-void urine. The device architecture also enables immediate mixing of the sample with a urine preservative, improving the stability of the sample.

Topics include: 

  • Why use first-void urine
  • Limitations with current cervical cancer screening methods
  • Potential of self-sampling methods, including urine sampling
  • Colli-Pee® as a urine collection device